Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Acquisitions (2023 - 2025)

Historic Acquisitions for Sanofi (SNY) over the last 3 years, with Q4 2025 value amounting to -$12.8 billion.

  • Sanofi's Acquisitions fell 37701.76% to -$12.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.9 billion, marking a year-over-year decrease of 16899.83%. This contributed to the annual value of -$12.4 billion for FY2025, which is 35755.15% down from last year.
  • Latest data reveals that Sanofi reported Acquisitions of -$12.8 billion as of Q4 2025, which was down 37701.76% from -$2.7 billion recorded in Q4 2024.
  • Sanofi's Acquisitions' 5-year high stood at -$90.2 million during Q1 2024, with a 5-year trough of -$12.8 billion in Q4 2025.
  • In the last 3 years, Sanofi's Acquisitions had a median value of -$3.0 billion in 2023 and averaged -$4.7 billion.
  • Its Acquisitions has fluctuated over the past 5 years, first skyrocketed by 2086.78% in 2024, then tumbled by 37701.76% in 2025.
  • Over the past 3 years, Sanofi's Acquisitions (Quarter) stood at -$3.4 billion in 2023, then grew by 20.87% to -$2.7 billion in 2024, then crashed by 377.02% to -$12.8 billion in 2025.
  • Its Acquisitions stands at -$12.8 billion for Q4 2025, versus -$2.7 billion for Q4 2024 and -$90.2 million for Q1 2024.